Showing 141-150 of 2447 results for "".
Redefining the Doctor-Patient Partnership: What a Physician-Patient Can Teach Us About Parkinson Disease Care
https://practicalneurology.com/diseases-diagnoses/movement-disorders/redefining-the-doctor-patient-partnership-what-a-physician-patient-can-teach-us-about-parkinson-disease-care/36532/How can neurologists partner with their patients living with Parkinson disease? Kathleen Blake, MD, MPH, Santa Fe, NM, Vice Chair of the Parkinson's Foundation People with Parkinson’s Advisory Council, discusses Parkinson disease care from her unique perspective as both a patient and former physiciaFrontal Temporal Dementia: A Disease in Progress
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0109_11-php/30963/Increasing knowledge about FTD has important practical implications for neurologists who must accurately diagnose and manage the condition. By Ronald Devere, MDNext-Generation CNS Drug Delivery: Brainshuttle Technology and Clinical Implications in Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/next-generation-cns-drug-delivery-brainshuttle-technology-and-clinical-implications-in-alzheimer-disease/67099/In this episode, Luka Kulic, MD, Vice President and Global Head of Early Clinical Development in Neuroscience and Rare Diseases at Roche, Basel, Switzerland, discusses the investigational Brainshuttle technology, including results from the BrainShuttle AD clinical trials as a treatment for early AlzNMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/nmosd-part-3-overview-of-treatment-including-goals-triggers-and-considerations-for-switching-therapies/30089/In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podPD GENEration and Barriers to Parkinson Diagnosis - Part 1
https://practicalneurology.com/diseases-diagnoses/movement-disorders/pd-generation-and-barriers-to-parkinson-diagnosis-part-1/30095/Chantale Branson, MD, Associate Professor of Neurology at Morehouse School of Medicine, Atlanta, GA, is a researcher working on the pivotal PD GENEration study, which aims to improve treatment options through the identification of clinically relevant genes linked to Parkinson disease. In this episodDetecting Multiple Sclerosis Earlier: PRLs and the Evolving McDonald Diagnostic Criteria
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/detecting-multiple-sclerosis-earlier-prls-and-the-evolving-mcdonald-diagnostic-criteria/54390/This episode explores new evidence showing that paramagnetic rim lesions (PRLs) are highly prevalent early in multiple sclerosis (MS) and can differentiate MS from mimics with striking accuracy. Daniel Ontaneda, MD, PhD, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, and Pascal Sati, PhYoung-Onset ALS: Diagnosis and Research
https://practicalneurology.com/diseases-diagnoses/neuromuscular/young-onset-als-diagnosis-and-research/30098/In this episode, Gwen Petersen discusses her long journey to receiving an ALS diagnosis at age 32, her contributions to a Cytokinetics book project, and the importance of clinical trial participation. We are also joined by Merit Cudkowicz, MD, MSc, Head of the Department of Neurology, Chief of NeuroNMOSD Part 2 - The importance and tools for monitoring NMOSD, and signs, symptoms and evaluation of disease activity
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/nmosd-part-2-the-importance-and-tools-for-monitoring-nmosd-and-signs-symptoms-and-evaluation-of-disease-activity/30088/In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podLearning, Laughing, and Living with Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/learning-laughing-and-living-with-multiple-sclerosis/37228/Ardra Shephard, a musician, author, fashion-show TV host, podcaster, and MS advocate, discusses her experiences living with MS, including how she uses her story to educate and encourage others living with MS. She is joined by Jiwon Oh, MD, Medical Director of the Barlo Multiple Sclerosis Program atCould a Novel Oral Therapy Change How Clinicians Treat Obstructive Sleep Apnea?Insights From the SynAIRgy Trial
https://practicalneurology.com/diseases-diagnoses/sleep/could-a-novel-oral-therapy-change-how-clinicians-treat-obstructive-sleep-apnea-insights-from-the-synairgy-trial/68963/In this episode, Patrick J. Strollo Jr, MD, FACP, FCCP, FAASM, of the University of Pittsburgh Department of Medicine, Pittsburgh, PA, discusses the data from the phase 3 SynAIRgy clinical trial for AD109, an investigational once-nightly oral treatment targeting neuromuscular dysfunction in obstruct